T-bet deficiency attenuates cardiac remodelling in rats

  • Zhen-Guo Ma
  • Jia Dai
  • Yu-Pei Yuan
  • Zhou-Yan Bian
  • Si-Chi Xu
  • Ya-Ge Jin
  • Xin Zhang
  • Qi-Zhu Tang
Original Contribution


Previous studies have suggested the involvement of CD4 + T lymphocytes in cardiac remodelling. T-bet can direct Th1 lineage commitment. This study aimed to investigate the functional significance of T-bet in cardiac remodelling induced by pressure overload using T-bet global knockout rats. Increased T-bet levels were observed in rodent and human hypertrophied hearts. T-bet deficiency resulted in a less severe hypertrophic phenotype in rats. CD4 + T-lymphocyte reconstitution in T-bet−/− rats resulted in aggravated cardiac remodelling. T-cell homing molecule expression and cytokine secretion were altered in T-bet-deficient rat hearts. Administration of exogenous interferon-γ (IFN-γ) offset T-bet deficiency-mediated cardioprotection. Cardiomyocytes cultured in T-bet−/− CD4 + T-cell-conditioned media showed a reduced hypertrophic response after hypertrophic stimuli, which was abolished by an IFN-γ-neutralizing antibody. Taken together, our findings show that T-bet deficiency attenuates pressure overload-induced cardiac remodelling in rats. Specifically, targeting T-bet in T cells may be of great importance for the treatment of pathological cardiac remodelling and heart failure.


T-bet Cardiac remodelling T lymphocytes T helper subset Interferon-γ 



This work was supported by Grants from the National Natural Science Foundation of China (Nos: 81270303, 81470516, 81470402, and 81700254) and the Key Project of the National Natural Science Foundation (No. 81530012) and the Fundamental Research Funds for the Central Universities (No. 2042017kf0085).

Compliance with ethical standards

Conflict of interest

The author(s) declare that they have no competing interests.

Supplementary material

395_2018_678_MOESM1_ESM.docx (2.1 mb)
Supplementary material 1 (DOCX 2115 kb)


  1. 1.
    Aukrust P, Ueland T, Muller F, Andreassen AK, Nordoy I, Aas H, Kjekshus J, Simonsen S, Froland SS, Gullestad L (1998) Elevated circulating levels of c-c chemokines in patients with congestive heart failure. Circulation 97:1136–1143CrossRefPubMedGoogle Scholar
  2. 2.
    Borthwick LA, Barron L, Hart KM, Vannella KM, Thompson RW, Oland S, Cheever A, Sciurba J, Ramalingam TR, Fisher AJ, Wynn TA (2016) Macrophages are critical to the maintenance of il-13-dependent lung inflammation and fibrosis. Mucosal Immunol 9:38–55. CrossRefPubMedGoogle Scholar
  3. 3.
    Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30–41. CrossRefPubMedGoogle Scholar
  4. 4.
    Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA (1999) An il-13 inhibitor blocks the development of hepatic fibrosis during a t-helper type 2-dominated inflammatory response. J Clin Invest 104:777–785. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Fang J, Hu F, Ke D, Yan Y, Liao Z, Yuan X, Wu L, Jiang Q, Chen L (2016) N, N-dimethylsphingosine attenuates myocardial ischemia-reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice. Basic Res Cardiol 111:32. CrossRefPubMedGoogle Scholar
  6. 6.
    Finotto S, Neurath MF, Glickman JN, Qin S, Lehr HA, Green FH, Ackerman K, Haley K, Galle PR, Szabo SJ, Drazen JM, De Sanctis GT, Glimcher LH (2002) Development of spontaneous airway changes consistent with human asthma in mice lacking t-bet. Science 295:336–338. CrossRefPubMedGoogle Scholar
  7. 7.
    Frieler RA, Mortensen RM (2015) Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 131:1019–1030. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F (2012) Interferon-gamma ablation exacerbates myocardial hypertrophy in diastolic heart failure. Am J Physiol Heart Circ Physiol 303:H587–H596. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG (2007) Role of the t cell in the genesis of angiotensin ii induced hypertension and vascular dysfunction. J Exp Med 204:2449–2460. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Jenner RG, Townsend MJ, Jackson I, Sun K, Bouwman RD, Young RA, Glimcher LH, Lord GM (2009) The transcription factors t-bet and gata-3 control alternative pathways of t-cell differentiation through a shared set of target genes. Proc Natl Acad Sci USA 106:17876–17881. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Ji YX, Zhang P, Zhang XJ, Zhao YC, Deng KQ, Jiang X, Wang PX, Huang Z, Li H (2016) The ubiquitin e3 ligase traf6 exacerbates pathological cardiac hypertrophy via tak1-dependent signalling. Nat Commun 7:11267. CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Jung M, Ma Y, Iyer RP, DeLeon-Pennell KY, Yabluchanskiy A, Garrett MR, Lindsey ML (2017) IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res Cardiol 112(3):33. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kamo T, Akazawa H, Komuro I (2015) Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ Res 117:89–98. CrossRefPubMedGoogle Scholar
  15. 15.
    Komuro I, Kurabayashi M, Takaku F, Yazaki Y (1988) Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62:1075–1079CrossRefPubMedGoogle Scholar
  16. 16.
    Laroumanie F, Douin-Echinard V, Pozzo J, Lairez O, Tortosa F, Vinel C, Delage C, Calise D, Dutaur M, Parini A, Pizzinat N (2014) Cd4 + t cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 129:2111–2124. CrossRefPubMedGoogle Scholar
  17. 17.
    Lazarevic V, Glimcher LH (2011) T-bet in disease. Nat Immunol 12:597–606. CrossRefPubMedGoogle Scholar
  18. 18.
    Lazarevic V, Glimcher LH, Lord GM (2013) T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol 13:777–789. CrossRefPubMedGoogle Scholar
  19. 19.
    Ma ZG, Dai J, Wei WY, Zhang WB, Xu SC, Liao HH, Yang Z, Tang QZ (2016) Asiatic acid protects against cardiac hypertrophy through activating ampkalpha signalling pathway. Int J Biol Sci 12:861–871. CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ma ZG, Dai J, Zhang WB, Yuan Y, Liao HH, Zhang N, Bian ZY, Tang QZ (2016) Protection against cardiac hypertrophy by geniposide involves the glp-1 receptor/ampkalpha signalling pathway. Br J Pharmacol 173:1502–1516. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ma ZG, Yuan YP, Xu SC, Wei WY, Xu CR, Zhang X, Wu QQ, Liao HH, Ni J, Tang QZ (2017) Ctrp3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Diabetologia 60:1126–1137. CrossRefPubMedGoogle Scholar
  22. 22.
    Ma ZG, Yuan YP, Zhang X, Xu SC, Wang SS, Tang QZ (2017) Piperine attenuates pathological cardiac fibrosis via ppar-gamma/akt pathways. EBioMedicine 18:179–187. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Marko L, Kvakan H, Park JK, Qadri F, Spallek B, Binger KJ, Bowman EP, Kleinewietfeld M, Fokuhl V, Dechend R, Muller DN (2012) Interferon-gamma signaling inhibition ameliorates angiotensin ii-induced cardiac damage. Hypertension 60:1430–1436. CrossRefPubMedGoogle Scholar
  24. 24.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB (2016) Heart disease and stroke statistics-2016 update: a report from the american heart association. Circulation 133:e38–e360. CrossRefPubMedGoogle Scholar
  25. 25.
    Nevers T, Salvador AM, Grodecki-Pena A, Knapp A, Velazquez F, Aronovitz M, Kapur NK, Karas RH, Blanton RM, Alcaide P (2015) Left ventricular t-cell recruitment contributes to the pathogenesis of heart failure. Circ Heart Fail 8:776–787. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Ramos G, Hofmann U, Frantz S (2016) Myocardial fibrosis seen through the lenses of t-cell biology. J Mol Cell Cardiol 92:41–45. CrossRefPubMedGoogle Scholar
  27. 27.
    Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U (2006) T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med 203:2009–2019. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Reifenberg K, Lehr HA, Torzewski M, Steige G, Wiese E, Kupper I, Becker C, Ott S, Nusser P, Yamamura K, Rechtsteiner G, Warger T, Pautz A, Kleinert H, Schmidt A, Pieske B, Wenzel P, Munzel T, Lohler J (2007) Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 171:463–472. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Sadoshima J, Izumo S (1993) Molecular characterization of angiotensin ii–induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the at1 receptor subtype. Circ Res 73:413–423CrossRefPubMedGoogle Scholar
  30. 30.
    Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T (2003) Imbalance of t-cell subsets in angiotensin ii-infused hypertensive rats with kidney injury. Hypertension 42:31–38. CrossRefPubMedGoogle Scholar
  31. 31.
    Shimoyama M, Hayashi D, Takimoto E, Zou Y, Oka T, Uozumi H, Kudoh S, Shibasaki F, Yazaki Y, Nagai R, Komuro I (1999) Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 100:2449–2454CrossRefPubMedGoogle Scholar
  32. 32.
    Simpson P, McGrath A, Savion S (1982) Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 51:787–801CrossRefPubMedGoogle Scholar
  33. 33.
    Stolarczyk E, Vong CT, Perucha E, Jackson I, Cawthorne MA, Wargent ET, Powell N, Canavan JB, Lord GM, Howard JK (2013) Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor t-bet. Cell Metab 17:520–533. CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, t-bet, directs th1 lineage commitment. Cell 100:655–669CrossRefPubMedGoogle Scholar
  35. 35.
    Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH (2002) Distinct effects of t-bet in th1 lineage commitment and ifn-gamma production in cd4 and cd8 t cells. Science 295:338–342. CrossRefPubMedGoogle Scholar
  36. 36.
    Tian X, Guo R, Zhang Y, Xu L, Liu X, Hou Y (2016) Effects of the sympathetic nervous system on regulatory t cell and t helper 1 chemokine expression in patients with acute coronary syndrome. Neuroimmunomodulat. Google Scholar
  37. 37.
    Wang H, Kwak D, Fassett J, Liu X, Yao W, Weng X, Xu X, Xu Y, Bache RJ, Mueller DL, Chen Y (2017) Role of bone marrow-derived CD11c + dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy. Basic Res Cardiol 112:25. CrossRefPubMedGoogle Scholar
  38. 38.
    Wei WY, Ma ZG, Xu SC, Zhang N, Tang QZ (2016) Pioglitazone protected against cardiac hypertrophy via inhibiting akt/gsk3beta and mapk signaling pathways. Ppar Res 2016:9174190. CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Wu QQ, Yuan Y, Jiang XH, Xiao Y, Yang Z, Ma ZG, Liao HH, Liu Y, Chang W, Bian ZY, Tang QZ (2016) Ox40 regulates pressure overload-induced cardiac hypertrophy and remodelling via cd4 + t-cells. Clin Sci (Lond) 130:2061–2071. CrossRefGoogle Scholar
  40. 40.
    Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D, Aragam J, Benjamin EJ, Cheng S, Wang TJ, Mitchell GF, Vasan RS (2016) Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community. JACC Heart Fail 4:808–815. CrossRefPubMedGoogle Scholar
  41. 41.
    Yndestad A, Holm AM, Muller F, Simonsen S, Froland SS, Gullestad L, Aukrust P (2003) Enhanced expression of inflammatory cytokines and activation markers in t-cells from patients with chronic heart failure. Cardiovasc Res 60:141–146CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Zhen-Guo Ma
    • 1
    • 2
    • 3
  • Jia Dai
    • 1
    • 2
    • 3
  • Yu-Pei Yuan
    • 1
    • 2
    • 3
  • Zhou-Yan Bian
    • 1
    • 2
    • 3
  • Si-Chi Xu
    • 1
    • 2
    • 3
  • Ya-Ge Jin
    • 1
    • 2
    • 3
  • Xin Zhang
    • 1
    • 2
    • 3
  • Qi-Zhu Tang
    • 1
    • 2
    • 3
  1. 1.Department of CardiologyRenmin Hospital of Wuhan UniversityWuhanPeople’s Republic of China
  2. 2.Cardiovascular Research InstituteWuhan UniversityWuhanPeople’s Republic of China
  3. 3.Hubei Key Laboratory of CardiologyWuhanPeople’s Republic of China

Personalised recommendations